MPWT
ALXO icon

MassMutual Private Wealth & Trust’s ALX Oncology ALXO Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,270
Closed -$2.12K – 2359
2024
Q4 		$2.12K Buy
+1,270
New +$1.95K ﹤0.01% 1822

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MassMutual Private Wealth & Trust's ALXO Position: Q1 2025 in Review

MassMutual Private Wealth & Trust sold out of ALX Oncology (ALXO) in Q1 2025, closing a stake of 1,270 shares — an estimated $2.12K sold.

MassMutual Private Wealth & Trust first reported a position in ALXO in Q4 2024 and held it in 1 quarter. The position peaked at $2.12K in Q4 2024. 85 funds tracked by Wall St. Rank hold ALXO as of Q1 2025.

  • MassMutual Private Wealth & Trust reported no remaining ALX Oncology position as of Q1 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 1,270 ALX Oncology shares in Q1 2025, an estimated $2.12K.
  • MassMutual Private Wealth & Trust first reported a position in ALX Oncology in Q4 2024 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's ALX Oncology position peaked at $2.12K in Q4 2024.
  • 85 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2025, filed 1 Apr 2025.